Drug Type Small molecule drug |
Synonyms BP C1 |
Target |
Action inhibitors |
Mechanism DNA inhibitors(DNA inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Pancreatic Cancer | Phase 2 | Egypt | 19 Dec 2014 | |
Pancreatic carcinoma non-resectable | Phase 2 | Egypt | 19 Dec 2014 | |
Metastatic breast cancer | Phase 2 | Russia | 24 Dec 2012 | |
Metastatic breast cancer | Phase 2 | Thailand | 24 Dec 2012 |
NCT03603197 (Pubmed) Manual | Phase 2 | 31 | obpielohus(fhngwzxosz) = nshowcgkeb zzoxcnddao (wlpzrzuqqo ) View more | Positive | 14 Jan 2019 | ||
Placebo | obpielohus(fhngwzxosz) = nhmvhwvcts zzoxcnddao (wlpzrzuqqo ) View more | ||||||
Not Applicable | 12 | ezrtghnnxv(aehqiibygu) = uapvrvevci zpcgqmvlok (uoownwchtx, 42.8–94.5) View more | Positive | 30 May 2017 | |||
Not Applicable | 30 | xczjshewmr(ndtrffwbmd) = few adverse events, which were mainly mild and manageable mwaokewcxt (ytjmdvprao ) | Positive | 01 Nov 2014 | |||
Placebo | |||||||
Not Applicable | - | ssqtcgrxne(ufrtuvcxad) = Differences in increase in QOL in favor of BP-C1 were detected for all variables yjoupxzxpc (xzpmmleskv ) | Positive | 20 May 2014 | |||
Placebo |